89bio, Inc.
NASDAQ:ETNB
8.29 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.234 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.012 | 0.009 | 0.016 | 0.01 | 0.052 | 0.055 | 0.055 | 0.06 | 0.107 | 0.018 | 0.021 | 0.023 | 0.02 | 0.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.012 | -0.009 | 0.218 | -0.01 | -0.052 | -0.055 | -0.055 | -0.06 | -0.107 | -0.018 | -0.021 | -0.023 | -0.02 | -0.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.932 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 44.865 | 47.428 | 33.592 | 31.417 | 34.915 | 22.306 | 19.064 | 22.197 | 19.686 | 19.849 | 20.979 | 23.59 | 15.63 | 10.131 | 8.77 | 11.208 | 8.443 | 7.778 | 7.192 | 6.68 | 3.165 | 4.309 | 3.692 | 3.289 |
| General & Administrative Expenses
| 8.571 | 9.849 | 7.614 | 7.928 | 7.214 | 6.218 | 6.298 | 4.844 | 5.052 | 5.259 | 5.262 | 4.622 | 4.921 | 4.608 | 3.777 | 3.225 | 3.23 | 2.924 | 2.419 | 1.518 | 0.834 | 0.523 | 0.716 | 0.497 |
| Selling & Marketing Expenses
| -0.012 | -0.009 | -0.016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.559 | 9.84 | 7.598 | 7.928 | 7.214 | 6.218 | 6.298 | 4.844 | 5.052 | 5.259 | 5.262 | 4.622 | 4.921 | 4.608 | 3.777 | 3.225 | 3.23 | 2.924 | 2.419 | 1.518 | 0.834 | 0.523 | 0.716 | 0.497 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.776 | 0.238 | -0.316 | -0.456 | -0.194 | -0.117 | -0.172 | -0.043 | -0.116 | -0.146 | -0.098 | 0.157 | -9.54 | -10.47 | -10.968 | 0.416 | -0.202 | -0.379 |
| Operating Expenses
| 53.424 | 57.268 | 41.19 | 39.345 | 42.129 | 28.524 | 25.362 | 27.041 | 24.738 | 25.108 | 26.241 | 28.212 | 20.551 | 14.739 | 12.547 | 14.433 | 11.673 | 10.702 | 9.611 | 8.198 | 3.999 | 4.832 | 4.408 | 3.786 |
| Operating Income
| -53.436 | -57.277 | -41.206 | -39.345 | -42.129 | 28.524 | 25.362 | -27.041 | -24.738 | -25.108 | -26.241 | -28.212 | -20.551 | -14.739 | -12.547 | -14.433 | -11.673 | -10.702 | -9.611 | -8.198 | -3.999 | -4.832 | -4.408 | -3.786 |
| Operating Income Ratio
| 0 | 0 | -176.094 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 5.599 | 5.693 | 4.838 | 4.62 | 3.736 | -57.36 | -49.948 | 0.238 | -0.316 | -0.456 | -0.194 | -0.117 | -0.172 | -0.043 | -0.116 | -0.146 | -0.098 | 0.157 | -9.54 | -10.47 | -10.968 | 0.416 | -0.202 | -0.379 |
| Income Before Tax
| -47.837 | -51.584 | -36.368 | -34.725 | -38.393 | -28.836 | -24.586 | -26.803 | -25.054 | -25.564 | -26.435 | -28.329 | -20.723 | -14.782 | -12.663 | -14.579 | -11.771 | -10.545 | -19.151 | -18.668 | -14.967 | -4.416 | -4.61 | -4.165 |
| Income Before Tax Ratio
| 0 | 0 | -155.419 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.134 | 0.097 | 3.867 | -0.01 | 4.63 | 55.285 | 0.016 | 0.002 | 0.316 | 0.001 | -0.147 | -0.023 | 0 | -0.015 | -0.082 | 0.024 | 0 | -0.001 | 0.132 | 0.057 | 0.006 | 0.023 | 0.028 | -0.001 |
| Net Income
| -47.971 | -51.681 | -40.235 | -34.725 | -38.393 | -84.121 | -24.602 | -26.805 | -25.37 | -25.565 | -26.288 | -28.329 | -20.723 | -14.782 | -12.581 | -14.606 | -11.771 | -10.544 | -19.283 | -18.725 | -14.973 | -4.439 | -4.638 | -4.165 |
| Net Income Ratio
| 0 | 0 | -171.944 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.48 | -0.54 | -0.5 | -0.45 | -0.52 | -1.58 | -0.48 | -0.57 | -1.25 | -1.26 | -1.3 | -1.41 | -1.03 | -0.74 | -0.63 | -0.87 | -0.85 | -0.76 | -2.58 | -1.55 | -3.27 | -0.97 | -1.01 | -0.91 |
| EPS Diluted
| -0.48 | -0.54 | -0.5 | -0.45 | -0.52 | -1.58 | -0.48 | -0.57 | -1.25 | -1.26 | -1.3 | -1.41 | -1.03 | -0.74 | -0.63 | -0.87 | -0.85 | -0.76 | -2.58 | -1.55 | -3.27 | -0.97 | -1.01 | -0.91 |
| EBITDA
| -53.424 | -57.268 | -41.19 | -39.345 | -37.489 | -26.761 | -25.362 | -27.025 | -24.722 | -25.09 | -26.241 | -28.212 | -20.531 | -14.739 | -12.547 | -14.433 | -11.656 | -10.69 | -9.611 | -8.193 | -3.995 | -4.829 | -4.406 | -3.786 |
| EBITDA Ratio
| 0 | 0 | -176.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |